Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2000

View Archived Issues

Myogen issued patent for heart failure combination

Organogenesis receives milestone payment related to Apligraf progress

Clinical trial of STR in Ewing's sarcoma initiated by NeoRx

Antagonists of alcohol's harmful effects in nerve cells discovered

Barr and DuPont mount development and marketing venture

Immunostimulatory sequence designed by Dynavax reduces HSV-2 severity

Vanguard Medical signs collaboration with WIBR for CNS disorders

Consensus receives SBIR grant to develop new class of HIV inhibitors

HPV vaccine alliance established by MediGene and Schering AG

Preliminary results from pivotal trial of Uniprost promising

ICAgen and Yamanouchi to develop novel CNS therapeutics

Agents for thrombocytopenia discovered at Kyowa Hakko

Sankyo presents newest antifungal triazoles

Potent antistaphylococcal activity exerted by Sankyo's new carbapenems

Novel antiviral agents in development at ViroPharma for Flaviviridae infections

Pfizer claims NSAIDs linked to NO-releasing moiety associated with reduced GI toxicity

Repligen initiates largest-ever study in autism

Novel peptides and their use in the treatment of diabetes reported by Amylin

Study indicates functional abnormalities in children with ADHD

ACS news: subtype-selective NMDA receptor antagonists with potential in PD

Benzimidazole inhibitors of V-ATPase designed at Fujisawa for osteoporosis Rx

SAR for beta-turn mimetics of enkephalin discussed at ACS by Molecumetics

Inhibitors of cdk2 pursued by CV Therapeutics for use in restenosis

HMR-1556 selected for further evaluation as antiarrhythmic agent, presented to ACS

AltaRex presents clinical plan for OvaRex at BIO 2000 annual meeting

KT3-671 beneficial in diabetic nephropathy according to recent preclinical results

SmithKline Beecham claims 5-HT6 antagonists for ADHD

Hemodynamic effects of AH-1058 evaluated by telemetry in dogs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...